Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 128
- Doi Number: 10.1182/blood.v128.22.852.852
- City: California
- Country: United States Of America
- Istanbul University Affiliated: Yes